Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
Objective: Neoantigens arising from gene mutations in tumors can induce specific immune responses, and neoantigen-based immunotherapies have been tested in clinical trials. Here, we characterized the efficacy of altered neoepitopes in improving immunogenicity against gastric cancer. Methods: Raw dat...
Guardado en:
Autores principales: | Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li, Yunbin Ye |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
China Anti-Cancer Association
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/12347c1122474a80bf017005f30ba371 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer
por: Jianming Wei, et al.
Publicado: (2021) -
Bioinformatics Analysis of Hub Genes and Potential Therapeutic Agents Associated with Gastric Cancer
por: Zhang S, et al.
Publicado: (2021) -
Elevated expression of NFE2L3 promotes the development of gastric cancer through epithelial-mesenchymal transformation
por: Xiaodong Wang, et al.
Publicado: (2021) -
LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis
por: Wei Yang, et al.
Publicado: (2021) -
Targeting Oncogenic miR-181a-2-3p Inhibits Growth and Suppresses Cisplatin Resistance of Gastric Cancer
por: Jin L, et al.
Publicado: (2021)